Elevance Health, Inc.
NYSE-ELV
Dec '05
Dec '09
Dec '13
Dec '17
Dec '21
LTM
| Income Statement | LTM | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 193,262 | 175,204 | 170,209 | 155,660 | 136,943 | 120,808 | 103,141 | 91,341 | 89,061 | 84,194 | 78,404.8 |
Total Revenues %Chg | 11.9% | 2.9% | 9.3% | 13.7% | 13.4% | 17.1% | 12.9% | 2.6% | 5.8% | 7.4% | 7.4% |
Cost of Sales | 165,326 | 147,317 | 141,623 | 129,677 | 113,466 | 96,998 | 83,778 | 71,895 | 72,236 | 66,834 | 61,116.9 |
Gross Profit | 27,936 | 27,887 | 28,586 | 25,983 | 23,477 | 23,810 | 19,363 | 19,446 | 16,825 | 17,360 | 17,287.9 |
Gross Profit Margin | 14.5% | 15.9% | 16.8% | 16.7% | 17.1% | 19.7% | 18.8% | 21.3% | 18.9% | 20.6% | 22% |
Selling, General & Administrative Expenses | 20,373 | 20,025 | 20,087 | 17,700 | 15,918 | 17,450 | 13,364 | 14,020 | 12,650 | 12,559 | 12,534.8 |
Depreciation & Amortization Expenses | 644 | 580 | 885 | 767 | 441 | 361 | 338 | 358 | 169 | 192 | 230.1 |
Other Operating Expenses | 20,373 | 20,025 | 20,087 | 17,700 | 15,918 | — | — | — | — | — | — |
Operating Profit | -13,454 | -12,743 | -12,473 | -10,184 | -8,800 | 5,999 | 5,661 | 5,068 | 4,006 | 4,609 | 4,523 |
Operating Margin | -7% | -7.3% | -7.3% | -6.5% | -6.4% | 5% | 5.5% | 5.5% | 4.5% | 5.5% | 5.8% |
Interest and Investment Income | 2,228 | 2,051 | 1,825 | 1,485 | 1,378 | 877 | 1,005 | 970 | 867 | 779 | 677.6 |
Interest Expense | -1,376 | -1,185 | -1,030 | -851 | -798 | -784 | -746 | -753 | -739 | -723 | -653 |
Non-Operating Income | -670 | -244 | -694 | -550 | 297 | 146 | 65 | -217 | -170 | -257 | 166.8 |
Total Non-Operating Income | 182 | 622 | 101 | 84 | 877 | 239 | 324 | — | -42 | -201 | 191.4 |
Income Before Provision for Income Taxes | 7,101 | 7,904 | 7,715 | 7,600 | 7,995 | 6,238 | 5,985 | 5,068 | 3,964 | 4,555 | 4,631 |
Provision for Income Taxes | 1,573 | 1,933 | 1,724 | 1,712 | 1,846 | 1,666 | 1,178 | 1,318 | 121 | 2,085 | 2,071 |
Consolidated Net Income | 5,528 | 5,971 | 5,991 | 5,888 | 6,149 | 4,572 | 4,807 | 3,750 | 3,843 | 2,470 | 2,560 |
Net Income Attributable to Minority Interests and Other | — | -9 | 4 | -6 | -9 | — | — | — | — | — | — |
Net Income Attributable to Discontinued Operations | — | — | — | — | — | — | — | — | — | — | — |
Net Income Attributable to Common Shareholders | 5,533 | 5,980 | 5,987 | 5,894 | 6,158 | 4,572 | 4,807 | 3,750 | 3,843 | 2,470 | 2,560 |
Basic EPS | 24.5 | 25.8 | 25.4 | 24.6 | 25.3 | 18.2 | 18.8 | 14.5 | 14.7 | 9.4 | 9.7 |
Diluted EPS | 24.5 | 25.7 | 25.2 | 24.3 | 25 | 18 | 18.5 | 14.2 | 14.4 | 9.2 | 9.4 |
Basic Weighted Average Shares Outstanding | 226.5 | 231.7 | 235.9 | 240 | 243.8 | 250.8 | 255.5 | 258.1 | 261.5 | 262.9 | 263 |
Total Shares Outstanding | 222.2 | 227.5 | 233.1 | 238 | 241.8 | 245.4 | 252.9 | 257.4 | 256.1 | 263.7 | 261.2 |
Diluted Weighted Average Shares Outstanding | 227 | 232.9 | 237.4 | 242.8 | 246.8 | 254.3 | 260.3 | 264.2 | 267.8 | 268.1 | 272.9 |
EBITDA | -11,916 | -11,350 | -10,728 | -8,509 | -7,498 | 7,153 | 6,794 | 6,200 | 4,897 | 5,521 | 5,430.9 |
Effective Tax Rate | 22.2% | 24.5% | 22.3% | 22.5% | 23.1% | 26.7% | 19.7% | 26% | 3.1% | 45.8% | 44.7% |